Continental Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-20,000
Closed -$303K 103
2017
Q4
$303K Sell
20,000
-63,000
-76% -$887K 0.07% 99
2017
Q3
$1.36M Buy
83,000
+63,000
+315% +$1.07M 0.31% 76
2017
Q2
$387K Sell
20,000
-41,100
-67% -$717K 0.09% 123
2017
Q1
$1.08M Sell
61,100
-2,000
-3% -$37.1K 0.24% 94
2016
Q4
$936K Buy
63,100
+5,100
+9% +$91.5K 0.25% 96
2016
Q3
$1.31M Buy
+58,000
New +$1.51M 0.37% 83
2016
Q2
Sell
-11,000
Closed -$318K 135
2016
Q1
$318K Sell
11,000
-25,000
-69% -$650K 0.09% 120
2015
Q4
$1.09M Buy
+36,000
New +$1.18M 0.28% 97

Other funds holding THC

Continental Advisors's THC Position: Q1 2022 in Review

Continental Advisors sold out of Tenet Healthcare (THC) in Q1 2022, closing a stake of 14,446 shares — an estimated $1.18M sold.

Continental Advisors first reported a position in THC in Q2 2014 and held it in 31 quarters. The position peaked at $5.85M in Q1 2018. 405 funds tracked by Wall St. Rank hold THC as of Q1 2022.

  • Continental Advisors reported no remaining Tenet Healthcare position as of Q1 2022 after selling out during the quarter.
  • Continental Advisors sold 14,446 Tenet Healthcare shares in Q1 2022, an estimated $1.18M.
  • Continental Advisors first reported a position in Tenet Healthcare in Q2 2014 and held it in 31 quarters.
  • Continental Advisors's Tenet Healthcare position peaked at $5.85M in Q1 2018.
  • 405 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2022.

Based on Continental Advisors's 13F filing for Q1 2022, filed 16 May 2022.